BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 19502975)

  • 21. Pain polymorphisms and opioids: An evidence based review.
    Vieira CMP; Fragoso RM; Pereira D; Medeiros R
    Mol Med Rep; 2019 Mar; 19(3):1423-1434. PubMed ID: 30592275
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacogenetics of opioids.
    Somogyi AA; Barratt DT; Coller JK
    Clin Pharmacol Ther; 2007 Mar; 81(3):429-44. PubMed ID: 17339873
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Implication of genetic polymorphism on neuropathic pain].
    Iseki M; Sato-Takeda M
    Masui; 2009 Sep; 58(9):1112-21. PubMed ID: 19764434
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetics and variability in opioid response.
    Stamer UM; Bayerer B; Stüber F
    Eur J Pain; 2005 Apr; 9(2):101-4. PubMed ID: 15737794
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prediction of codeine toxicity in infants and their mothers using a novel combination of maternal genetic markers.
    Sistonen J; Madadi P; Ross CJ; Yazdanpanah M; Lee JW; Landsmeer ML; Nauta M; Carleton BC; Koren G; Hayden MR
    Clin Pharmacol Ther; 2012 Apr; 91(4):692-9. PubMed ID: 22398969
    [TBL] [Abstract][Full Text] [Related]  

  • 26. How individual sensitivity to opiates can be predicted by gene analyses.
    Ikeda K; Ide S; Han W; Hayashida M; Uhl GR; Sora I
    Trends Pharmacol Sci; 2005 Jun; 26(6):311-7. PubMed ID: 15925706
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [How can we cope with wide individual variations in pain intensity and opioid requirements after surgery?].
    Hayashida M; Maruyama K
    Masui; 2009 Sep; 58(9):1086-92. PubMed ID: 19764430
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interethnic differences in genetic polymorphisms of CYP2D6 in the U.S. population: clinical implications.
    Bernard S; Neville KA; Nguyen AT; Flockhart DA
    Oncologist; 2006 Feb; 11(2):126-35. PubMed ID: 16476833
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A118G single nucleotide polymorphism of human mu-opioid receptor gene influences pain perception and patient-controlled intravenous morphine consumption after intrathecal morphine for postcesarean analgesia.
    Sia AT; Lim Y; Lim EC; Goh RW; Law HY; Landau R; Teo YY; Tan EC
    Anesthesiology; 2008 Sep; 109(3):520-6. PubMed ID: 18719451
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Individual differences in analgesic effects of narcotics].
    Ide S; Kasai S; Ikeda K
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2008 Feb; 28(1):43-8. PubMed ID: 18411709
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fundamental Considerations for Genetically-Guided Pain Management with Opioids Based on CYP2D6 and OPRM1 Polymorphisms.
    Ruano G; Kost JA
    Pain Physician; 2018 Nov; 21(6):E611-E621. PubMed ID: 30508992
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Opioid genetics in the context of opioid switching.
    Droney J; Riley J; Ross J
    Curr Opin Support Palliat Care; 2012 Mar; 6(1):10-6. PubMed ID: 22228031
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Opioid pharmacology.
    Trescot AM; Datta S; Lee M; Hansen H
    Pain Physician; 2008 Mar; 11(2 Suppl):S133-53. PubMed ID: 18443637
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Side effects of opioid and gene variants].
    Sora I; Komatsu H; Igari M; Ide S; Ikeda K; Shimoyama N
    Masui; 2009 Sep; 58(9):1109-11. PubMed ID: 19764433
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Global genetic variation of select opiate metabolism genes in self-reported healthy individuals.
    Wendt FR; Pathak G; Sajantila A; Chakraborty R; Budowle B
    Pharmacogenomics J; 2018 Apr; 18(2):281-294. PubMed ID: 28398354
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Environmental and genetic factors associated with morphine response in the postoperative period.
    Coulbault L; Beaussier M; Verstuyft C; Weickmans H; Dubert L; Trégouet D; Descot C; Parc Y; Lienhart A; Jaillon P; Becquemont L
    Clin Pharmacol Ther; 2006 Apr; 79(4):316-24. PubMed ID: 16580900
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic variability and clinical efficacy of morphine.
    Klepstad P; Dale O; Skorpen F; Borchgrevink PC; Kaasa S
    Acta Anaesthesiol Scand; 2005 Aug; 49(7):902-8. PubMed ID: 16045647
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The current status of association studies in obsessive-compulsive disorder.
    Hemmings SM; Stein DJ
    Psychiatr Clin North Am; 2006 Jun; 29(2):411-44. PubMed ID: 16650716
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between OPRM1 gene polymorphisms and fentanyl sensitivity in patients undergoing painful cosmetic surgery.
    Fukuda K; Hayashida M; Ide S; Saita N; Kokita Y; Kasai S; Nishizawa D; Ogai Y; Hasegawa J; Nagashima M; Tagami M; Komatsu H; Sora I; Koga H; Kaneko Y; Ikeda K
    Pain; 2009 Dec; 147(1-3):194-201. PubMed ID: 19783098
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacogenetics of opiates in clinical practice: the visible tip of the iceberg.
    Hajj A; Khabbaz L; Laplanche JL; Peoc'h K
    Pharmacogenomics; 2013 Apr; 14(5):575-85. PubMed ID: 23556453
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.